BetterLife Pharma Inc. Files August 2024 6-K Report
Ticker: BETRF · Form: 6-K · Filed: Aug 29, 2024 · CIK: 1464165
| Field | Detail |
|---|---|
| Company | Betterlife Pharma INC. (BETRF) |
| Form Type | 6-K |
| Filed Date | Aug 29, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, regulatory-filing, foreign-private-issuer
TL;DR
BetterLife Pharma filed its monthly 6-K report, standard procedure for foreign issuers.
AI Summary
BetterLife Pharma Inc. filed a Form 6-K on August 29, 2024, reporting for the month of August 2024. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is based in Vancouver, BC. This filing is a routine report for a foreign private issuer.
Why It Matters
This filing provides an update on BetterLife Pharma Inc.'s regulatory reporting status as a foreign private issuer, which is important for investors tracking the company's compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain new material financial or operational information that would typically increase risk.
Key Players & Entities
- BetterLife Pharma Inc. (company) — Filer of the report
- Pivot Pharmaceuticals Inc. (company) — Former name of BetterLife Pharma Inc.
- Neurokine Pharmaceuticals Inc. (company) — Former name of BetterLife Pharma Inc.
- August 29, 2024 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers which provides information that the issuer makes or is required to make public pursuant to the laws of the issuer's home country, or is required to file with or submit to any stock exchange on which its securities are traded, or is distributed or is required to be distributed to its security holders.
What is BetterLife Pharma Inc.'s principal executive office address?
BetterLife Pharma Inc.'s principal executive office is located at 1275 West 6th Avenue, #300, Vancouver, BC V6H 1A6.
When did BetterLife Pharma Inc. change its name from Pivot Pharmaceuticals Inc.?
BetterLife Pharma Inc. changed its name from Pivot Pharmaceuticals Inc. on April 17, 2015.
Is BetterLife Pharma Inc. required to file annual reports on Form 20-F or Form 40-F?
Yes, BetterLife Pharma Inc. indicates it files annual reports under cover of Form 20-F.
What is the SIC code for BetterLife Pharma Inc.?
The Standard Industrial Classification (SIC) code for BetterLife Pharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 343 words · 1 min read · ~1 pages · Grade level 14.8 · Accepted 2024-08-29 16:19:21
Filing Documents
- betrf_6k.htm (6-K) — 10KB
- betrf_ex991.htm (EX-99.1) — 29KB
- betrf_ex991img3.jpg (GRAPHIC) — 4KB
- betrf_ex991img4.jpg (GRAPHIC) — 4KB
- 0001477932-24-005379.txt ( ) — 51KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 , the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BETTERLIFE PHARMA INC. Date: August 29, 2024 By: /s/ Moira Ong Name: Moira Ong Title: Chief Financial Officer 3